Catalyst Wire Dossier Catalyst Wire Dossier

NRX101

· NeuroRx, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NRX101, covering 2022-08-09 to 2022-08-09. Get the full timeline:

Most recent: Clinical Trial Update: NRX101 Glx Biomarker Validation Study [Phase 2, Phase 3]

See pricing